These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1496827)

  • 21. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
    Sandborn WJ; Hanauer SB; Buch A
    Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmortem analysis of famprofazone and its metabolites, methamphetamine and amphetamine, in porcine bone marrow.
    de Souza Santos E; Spinelli E; Vieira AA; Rodrigues SV
    Talanta; 2019 Jan; 191():545-552. PubMed ID: 30262097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1.
    Foster BJ; Wiegand RA; LoRusso PM; Baker LH
    Clin Cancer Res; 1995 Aug; 1(8):831-7. PubMed ID: 9816052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of famprofazone, amphetamine and methamphetamine in liver samples using enzymatic cell dispersion and SPE-LC-ESI-MS.
    da Silva CML; Spinelli E; Rodrigues SV
    J Pharm Biomed Anal; 2022 Aug; 217():114821. PubMed ID: 35598557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration.
    Hackett AM; Griffiths LA; Broillet A; Wermeille M
    Xenobiotica; 1983 May; 13(5):279-86. PubMed ID: 6636824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic fate of 14C-ximoprofen in rats, baboons and humans.
    Mayo BC; Chasseaud LF; Hawkins DR; Taylor IW; Legeai J
    Xenobiotica; 1990 Mar; 20(3):233-46. PubMed ID: 2336835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man.
    Bondesson U; Hartvig P; Danielsson B
    Drug Metab Dispos; 1981; 9(4):376-80. PubMed ID: 6114838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetics of pirazolac in human subjects.
    Täuber U
    Drugs Exp Clin Res; 1990; 16(1):7-15. PubMed ID: 2376240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination pathways of [14C]losoxantrone in four cancer patients.
    Joshi AS; Pieniaszek HJ; Vokes EE; Vogelzang NJ; Davidson AF; Richards LE; Chai MF; Finizio M; Ratain MJ
    Drug Metab Dispos; 2001 Feb; 29(2):96-9. PubMed ID: 11159796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in patients with impaired liver function.
    Valles J; Artigas R; Bertolotti M; Crea A; Muller F; Paredes I; Capriati A
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():29-36. PubMed ID: 16801990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
    Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
    Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat.
    Carini M; Aldini G; Orioli M; Piccoli A; Rossoni G; Maffei Facino R
    Life Sci; 2004 May; 74(26):3291-305. PubMed ID: 15094329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of the non-steroidal anti-inflammatory drug niflumic acid in humans: a combined 19F-MRS in vivo and in vitro study.
    Bilecen D; Schulte AC; Kaspar A; Küstermann E; Seelig J; Elverfeldt D; Scheffler K
    NMR Biomed; 2003 May; 16(3):144-51. PubMed ID: 12884358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone).
    Volz M; Kellner HM
    Br J Clin Pharmacol; 1980 Oct; 10 Suppl 2(Suppl 2):299S-308S. PubMed ID: 7002187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methamphetamine disposition in oral fluid, plasma, and urine.
    Huestis MA; Cone EJ
    Ann N Y Acad Sci; 2007 Mar; 1098():104-21. PubMed ID: 17332086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary excretion of methaqualone-N-oxide in man.
    Reynolds CN; Wilson K; Burnett D
    Xenobiotica; 1976 Feb; 6(2):113-24. PubMed ID: 1274373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.